Sabine,Ph.D. Wilhelm, PhD
Sabine Wilhelm, Ph.D., is a Professor at Harvard Medical School (HMS) and Chief of Psychology as well as Director of the Center for OCD and Related Disorders (CORD) at Massachusetts General Hospital (MGH). She is also the Director of the Center for Digital Mental Health in Psychiatry at MGH. Dr. Wilhelm is recognized as a leading researcher in obsessive-compulsive and related disorders. Her recent research focuses on using cutting-edge technology to improve and personalize mental health care for a range of mental health concerns. Dr. Wilhelm has published over 325 papers, including seven books, and has given more than 290 lectures on these subjects. She has been a mentor to 50 junior investigators in the field. She is currently working on smartphone-based treatments for OCD, depression, and body dysmorphic disorder. Her ultimate goal is to use technology-based interventions to enhance global access to high-quality mental health interventions. Dr. Wilhelm is the Vice-Chair of the Scientific Advisory Board of the International OCD Foundation. She serves on the Scientific Council for the Anxiety and Depression Association of America and the Tourette Syndrome Association Behavioral Science Consortium. Dr. Wilhelm is the past president of the Association for Behavioral and Cognitive Therapies (ABCT), and she was an Associate Editor for the journals Depression and Anxiety and Behavior Therapy. She currently serves on eight editorial boards. She was the Scientific Program Chair of the World Congress of Behavioral and Cognitive Therapies held in Boston in June 2010. Additionally, Dr. Wilhelm is a fellow of the Association for Psychological Science. Dr. Wilhelm received many awards, including the Peter K. Ranney Innovation Award from the World Medical Innovation Forum for her presentation “Bridging the Mental Health Treatment Gap” and the Claflin Distinguished Scholar in Medicine Award. Dr. Wilhelm has been the principal investigator or site principal investigator of seven NIMH-funded research grants. She is also the principal investigator of several privately funded clinical research studies investigating medication, cognitive-behavioral therapy, digital services, and other treatments for a range of psychiatric disorders in children and adults.
There are no financial relationships to disclose.